About this trial
The project 'My Symptoms' is part of a large research programme: eHealth and GP-assisted self-help interventions for persistent physical symptoms (eASY). See www.mine-symptomer.dk.
The research programme is an ambitious and dedicated effort aiming at improvement of functioning and quality of life for individuals with persistent physical symptoms (PPS) and prevention of the development of chronic functional disorders and associated loss of working capacity and high use of health care. At present, access to specialized treatment of PPS is very limited and treatment capacity in general practice is restricted to brief consultations - often with poor opportunity to make a treatment plan for symptoms. As part of the research programme, the investigators have developed a web-based self-help programme for patient with PPS. This treatment programme is prescribed by the patient's general practitioner (GP). Only GPs who have participated in a short introduction course will be allowed for prescriptions.
The investigators have applied a high degree of user involvement (GPs and patients) in the development process but there is a need to evaluate how the new treatment programme is in fact adopted by GPs and patients.
With this study, the investigators wish to follow the national implementation using a before-after study design describing uptake and effects on GPs, patients and the health care system.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age 18-65 (target population for the programme)
The consultation targets symptom complaints
Listed with participating practice.
Disqualifiers
Symptoms are acute (not persistent) and there is no need for this intervention
Symptoms must primarily be treated by medicine or surgery
Patient severely affected by other disease
Not eligible due to language or cognitive problems
Trial population
Only patients who consult their GP will be eligible for participation. Patients will need a referral from their GP to be able to access the 'My Symptoms' programme using a specific code. All patients who consent to participate and login to the programme will be included in the present study. The GP will assess whether prescription of the 'My Symptoms' programme is relevant. As a guide for this assessment, the GP will be provided with the inclusion and exclusion criteria during their training programme.
Trial design
Case-only
Prospective
Treatments tested in this trial
My Symptoms eHealth programme
BehavioralMy Symptoms supports patients' self-efficacy and behavioural changes. The programme is activated by the patient after prescription by the GP. The patient is free to choose relevant tasks corresponding to wishes, needs/requirements and own perspectives. Summary of content: 1. Symptom explanations and facts about frequent symptoms including brief animated explanations 2. Physical energy (sleep, diet and activity) 3. Working with resources and strain in everyday life 4. Values and choices (meaning and existential issues) 5. Thoughts 6. Feelings (emotion regulation) 7. Self-care (attention incl. mindfulness and audio exercises) 8. Preparation for a follow-up visit with the GP and relapse prevention. The above modules connect to four general tools: symptom registration, 'don't break the chain', goal setting staircase and notebook. After 6 weeks: Voluntary GP follow-up consultation. After 8 weeks: End-of-treatment.
Treatment groups
Trial outcomes
Primary outcomes
Change in symptom intensity
Symptom intensity measured by a numeric rating scale (0-10)
Change in symptom interference
Symptom interference measured by a numeric rating scale (0-10)
Secondary outcomes
Change in symptom intensity
Symptom intensity measured by a numeric rating scale (0-10)
Change in symptom interference
Symptom interference measured by a numeric rating scale (0-10)
Change in symptom burden
Bodily Distress Syndrome (BDS) Checklist measuring symptom burden (0-100)
Change in symptom burden
Bodily Distress Syndrome (BDS) Checklist measuring symptom burden (0-100)
Sponsors and contacts
Click on the lead sponsor to view all of their trials.